mFOLFIRINOX
Showing 1 - 25 of 98
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Pancreatic Cancer Trial in Nanjing (Cadonilimab+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Nov 23, 2023
Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)
Recruiting
- Adenocarcinoma, Pancreatic Ductal
- Autogene cevumeran
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 21, 2023
Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023
Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
- BNT321 Dose Level 1
- +3 more
- (no location specified)
Sep 29, 2023
Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Ivosidenib
- mFOLFIRINOX
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022
Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- NP137
- +4 more
- (no location specified)
Sep 23, 2022
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX
- Gemcitabine / Nab-paclitaxel
-
Hamilton, Ontario, CanadaJuravinski Hospital
Aug 5, 2022
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Cancer Non-resectable
- SBRT+mFOLFIRINOX
- mFOLFIRINOX
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 24, 2022
Locally-advanced Rectal Cancer Trial in Lyon, Villejuif (mFOLFIRINOX, Pelvic radiotherapy LCRT, Capecitabine)
Not yet recruiting
- Locally-advanced Rectal Cancer
- mFOLFIRINOX
- +6 more
-
Lyon, Rhöne, France
- +1 more
Jun 12, 2023
Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)
Active, not recruiting
- Pancreatic Cancer
- mFOLFIRINOX
- +2 more
-
Scottsdale, Arizona
- +7 more
Feb 14, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus
Recruiting
- Borderline Resectable Pancreatic Cancer
- Locally Advanced Pancreatic Adenocarcinoma
- Nab paclitaxel plus gemcitabine
- mFOLFIRINOX
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022
Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,
Recruiting
- Unresectable Pancreatic Cancer
- Suizenji
- +3 more
-
Sendai-shi, Miyagi, Japan
- +2 more
Jan 31, 2023
Pancreatic Cancer Trial in Seoul (Chlorphenesin Carbamate, Hydroxychloroquine)
Recruiting
- Pancreatic Cancer
- Chlorphenesin Carbamate, Hydroxychloroquine
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 23, 2022
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Early Luminal Breast Cancer and Pancreatic Cancer Patients
Recruiting
- Breast Cancer
- Pancreas Cancer
- mFOLFIRINOX
- +4 more
-
Moscow, Not Required, Russian FederationMoscow Clinical Scientific Center named after AS Loginov
Oct 12, 2022
Colorectal Cancer Stage IV Trial in Sao Paulo (mFOLFIRINOX)
Recruiting
- Colorectal Cancer Stage IV
- mFOLFIRINOX
-
Sao Paulo, SP, BrazilICESP
Apr 28, 2022
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin
Recruiting
- Pancreatic Cancer
- +2 more
- Leucovorin Calcium
- +4 more
-
's-Hertogenbosch, Netherlands
- +19 more
Jan 6, 2023
Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic
Recruiting
- Liver and Intrahepatic Bile Duct Carcinoma
- +5 more
- Dexamethasone
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Oct 11, 2022